Skip to main content
SpringerLink
Log in

Genetic polymorphism in the second exon of HLA-DRB1 in cervical cancer

  • Published:
Clinical Oncology and Cancer Research

Abstract

Objective

The aim of this investigation was to assess the association between single nucleotide polymorphisms (SNPs) in HLA-DRB1 and the risk of developing cervical cancer. Our study focused on the second exon of the HLA-DRB1 alleles, which have most of the SNP sites on HLA-DRB1.

Methods

We examined 30 cervical cancer patients and 66 control patients using the sequence-based typing polymerase chain reaction technique (PCR-SBT) to type 55 single nucleotide polymorphisms (SNPs) and haplotypes in the second exon of HLA-DRB1. The Chi-square test and the Bonferroni correction method were utilized for the statistical analysis of the data. An association between the alleles and cervical cancer was examined by the linkage disequilibrium test and the odds ratio (OR).

Results

Compared with the control group, among the 55 SNPs we studied in the second exon of HLA-DRB1, 4 showed an evident association with cervical cancer. Rs17880292 (P = 0.033, OR = 0.322) and rs1059586 (P = 0.029, OR = 2.657) had positive significance for the risk of developing cervical cancer, while rs17879702 (P = 0.016, OR = 0.222) and rs17882525 (P = 0.025, OR = 0.128) were negative. The diff erence in frequency of the 5582A-5592A-5667T haplotype between cervical cancer patients and the controls was significant (P = 0.043, OR = 2.735).

Conclusion

The rs17880292 G/A genotype and the rs1059586 A/A genotype could be linked to an increased risk of cervical cancer. Rs17879702 and rs17882525 might be haplotype-tag SNPs (htSNPs) or belong to some other haplotypes, which might exert a protective effect against cervical cancer in combination. The 582A-5592A-5667T haplotype was shown to be a marker for susceptibility to cervical carcinogenesis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 1999; 80: 827–841.

    Article  CAS  PubMed  Google Scholar 

  2. Parkin DM, Bray F, Ferlay J, et al. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001; 94: 153–156.

    Article  CAS  PubMed  Google Scholar 

  3. Muñoz N, Bosch FX, Castellsagué X, et al. Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer 2004; 111: 278–285.

    Article  PubMed  Google Scholar 

  4. Kohaar I, Thakur N, Salhan S. TNFα-308G/A polymorphism as a risk factor for HPV associated cervical cancer in the Indian population. Cellular Oncology 2007; 29: 249–256.

    CAS  PubMed  Google Scholar 

  5. Taillon-Miller P, Bauer-Sardina I, Saccone NL, et al. Juxtaposed regions of extensive and minimal linkage disequilibrium in human Xq25 and Xq28. Nat Genet 2000; 25: 324–328.

    Article  CAS  PubMed  Google Scholar 

  6. Madeleine MM, Brumback B, Cushing-Haugen KL, et al. Human leukocyte antigen class II and cervical cancer risk: a population-based study. J Infect Dis 2002; 186: 1565–1574.

    Article  CAS  PubMed  Google Scholar 

  7. Davidson EJ, Davidson JA, Sterling JC, et al. Association between human leukocyte antigen polymorphism and human papillomavirus 16-positive vulval intraepithelial neoplasia in British women. Cancer Res 2003; 63: 400–403.

    CAS  PubMed  Google Scholar 

  8. Allen M, Kalantari M, Ylitalo N, et al. HLADQ-DR haplotype and susceptibility to cervical carcinoma: indications of increased risk for development of cervical carcinoma in individuals infected with HPV 18. Tissue Antigens 1996; 48: 32–37.

    Article  CAS  PubMed  Google Scholar 

  9. Lin P, Koutsky LA, Critchlow CW, et al. HLA class II DR-DQ and increased risk of cervical cancer among Senegalese women. Cancer Epidemiol Biomarkers Prev 2001; 10: 1037–1045.

    CAS  PubMed  Google Scholar 

  10. Wu Y, Liu B, Lin W, et al. Human leukocyte antigen class II alleles and risk of cervical cancer in China. Hum Immunol 2007; 68: 192–200.

    Article  CAS  PubMed  Google Scholar 

  11. Beskow AH, Josefsson AM, Gyllensten UB. HLA class II alleles associated with infection by HPV16 in cervical cancer in situ. Int J Cancer 2001; 93: 817–22.

    Article  CAS  PubMed  Google Scholar 

  12. Wu Y, Chen Y, Li L, et al. Polymorphic amino acids at codons 9 and 37 of HLADQB1 alleles may confer susceptibility to cervical cancer among Chinese women. Int J Cancer 2006; 118: 3006–3011.

    Article  CAS  PubMed  Google Scholar 

  13. Dehaghani AS, Amirzargar A, Farjadian S, et al. HLADQBl alleles and susceptibility to cervical squamous cell carcinoma in Southern Iranian patients. Pathol Oncol Res 2002; 8: 58–61.

    Article  CAS  PubMed  Google Scholar 

  14. Apple RJ, Erlich HA, Klitz W, et al. HLADR-DQ associations with cervical carcinoma show papillomavirus-type specificity. Nat Genet 1994; 6: 157–162.

    Article  CAS  PubMed  Google Scholar 

  15. Sastre-Garau X, Loste MN, Vincent-Salomon A, et al. Decreased frequency of HLA-DRB1 13 alleles in Frenchwomen with HPV-positive carcinoma of the cervix. Int J Cancer 1996; 69: 159–164.

    Article  CAS  PubMed  Google Scholar 

  16. Wank R, Thomssen C. High risk of squamous cell carcinoma of the cervix for women with HLA-DQw3. Nature 1991; 352: 723–725.

    Article  CAS  PubMed  Google Scholar 

  17. Silva B, Vargas-Alarcon G, Zuniga-Ramos J, et al. Genetic features of Mexican women predisposing to cancer of the uterine cervix. Hum Pathol 1999; 30: 626–628.

    Article  CAS  PubMed  Google Scholar 

  18. Wang SS, Wheeler CM, Hildesheim A, et al. Human leukocyte antigen class I and II alleles and risk of cervical neoplasia: results from a population-based study in Costa Rica. J Infect Dis 2001; 184: 1310–1314.

    Article  CAS  PubMed  Google Scholar 

  19. Hughes AL, Yeager M. Natural selection at major histocompatibility complex loci of vertebrates. Annu Rev Genet 1998; 32: 415–435.

    Article  CAS  PubMed  Google Scholar 

  20. Hadden JW. Immunotoxicology and Immunopharmacology. Adv Exp Med Biol 1991; 288: 1–11.

    CAS  PubMed  Google Scholar 

  21. Marincola FM, Shamamian P, Rivoltini L, et al. HLA associations in the antitumor response against malignant melanoma. J Immunother Emphasis Tumor Immunol 1995; 18: 242–252.

    CAS  PubMed  Google Scholar 

  22. Horne BD, Camp NJ. Principal component analysis for selection of optimal SNP-sets that capture intragenic genetic variation. Genet Epidemiol 2004; 26: 11–21.

    Article  PubMed  Google Scholar 

  23. Johnson GC, Esposito L, Barratt BJ, et al. Haplotype tagging for the identification of common disease genes. Nat Genet 2001; 29: 233–237.

    Article  CAS  PubMed  Google Scholar 

  24. Zhang K, Deng M, Chen T, et al. A dynamic programming algorithm for haplotype block partitioning. Proc Natl Acad Sci USA 2002; 99: 7335–7339.

    Article  CAS  PubMed  Google Scholar 

  25. Zhang K, Calabrese P, Nordborg M, et al. Haplotype block structure and its applications to association studies: power and study designs. Am J Hum Genet 2002; 71: 1386–1394.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biochemistry and Molecular Biology, Basic Medical College, Tianjin Medical University, Tianjin, 300070, China

    Yan-yun Li, Gui-fang Yang, Yan-ju Jia, Jun Xing, Yan-ni Li & Wei-ming Zhang

Authors
  1. Yan-yun Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gui-fang Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yan-ju Jia
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jun Xing
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yan-ni Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Wei-ming Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Wei-ming Zhang.

About this article

Cite this article

Li, Yy., Yang, Gf., Jia, Yj. et al. Genetic polymorphism in the second exon of HLA-DRB1 in cervical cancer. Clin. Oncol. Cancer Res. 7, 27–32 (2010). https://doi.org/10.1007/s11805-010-0027-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11805-010-0027-9

Key Words

Search

Navigation